HOME >> BIOLOGY >> NEWS
Yale BioHaven Entrepreneurship Seminars begin with TheraLogics

New Haven, Conn. --The Yale BioHaven Entrepreneurship Seminars series begins its fall schedule on Wednesday, September 20 from 3:30 to 5 p.m. in the Anlyan Center Auditorium of Yale Medical School, 300 Cedar Street.

This program will feature TheraLogics, Inc., a technology start-up company that is unusual because it has not received -- and is not seeking -- venture capital investments. Rather, it is funded through licensing agreements of technology previously developed by one co-founder of the company. TheraLogics also anticipates participating in a non-profit foundation as a potential source of research revenue.

Speakers are Max Wallace, the C.E.O. of TheraLogics and former C.E.O. of Trimeris Pharmaceuticals; and Sankar Ghosh, professor of immunobiology, and molecular biophysics & biochemistry at Yale University and co-founder of TheraLogics.

Many major human diseases, including arthritis, asthma, colitis, and cancer can be attributed to problems related to regulation of the transcription factor NF-kB. The goal of TheraLogics is to develop effective inhibitors of NF-kB and to bring these drugs into the clinical arena by establishing a network of investigators in academia and biopharm, who are each focusing on one of the major NF-kBrelevant target diseases.

Wallace and Ghosh will discuss how they have managed to move from basic research to applying a technology rapidly, even though TheraLogics has yet to make itself visible on the web or with a physical research facility. Their intention is to show potential academic founders and entrepreneurs a new model for translating technologies.

Refreshments and networking will follow the seminar from 5 to 7 p.m. Registration is free, but advance RSVP to Larry Banks at larry.banks@yale.edu or the Yale Office of Cooperative Research at 203-436-8096 is required. Directions to the event are available on line at

Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
14-Sep-2006


Page: 1 2

Related biology news :

1. Yale-BioHaven Entrepreneurship Seminar: 454 Life Sciences aiming for the $10K Human Genome
2. Yale BioHaven Entrepreneurship Seminar series launched
3. Developer of new method for treating bone defects wins WPI Entrepreneurship Award
4. Device that aids people with muscular dystrophy wins inaugural WPI Entrepreneurship Award
5. Institute for OneWorld Health awarded Skoll Foundations Social Entrepreneurship Award
6. Study begins to reveal clues to the cause and progression of sepsis
7. Immunity in social amoeba suggests ancient beginnings
8. Alzheimers drug based on Purdue -- designed inhibitor begins clinical trials
9. Food safety begins as vegetables grow
10. Cancer scientists create human leukemia process to map how disease begins, progresses
11. Researchers begin Project 3000, a recipe for hope through genetic research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... ... 18, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology ... and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application ... COVID-19. Approval of this IND allows Sentien to initiate a Phase 1/2 study ...
(Date:8/21/2020)... BOSTON (PRWEB) , ... August 19, 2020 , ... ... , the premier conference and expo uniting life science, data science, informatics and ... keynote sessions. , “In this period of uncertainty and change, Bio-IT takes the ...
(Date:8/12/2020)... ... August 11, 2020 , ... Both Roche, based in Basel, ... license agreements with Housey Pharma’s HMI subsidiary to gain access to its core-enabling ... Research and Development spending in excess of US $10 billion. , Scientists at ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... Ky. (PRWEB) , ... August 03, 2020 , ... Introducing ... products for transformative growth, , Known as MediVet Biologics since ... brand. , The new Ardent Animal Health will build on its base ...
(Date:7/31/2020)... and SOMERSET, N.J (PRWEB) , ... July 29, ... ... genome editing company, and Catalent, the leading global provider of advanced delivery technologies, ... health products, today announced that they have entered into a strategic partnership whereby ...
(Date:7/18/2020)... ... , ... After research model surgery and catheter implantation, the long journey of ... beginning of a successful study, while protecting and accessing the catheter or device post-surgery ... Surgery from Envigo in a live webinar on Wednesday, August ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... announced today that Massachusetts Institute of Technology (MIT) has expanded the company’s ... allows PathSensors to move into the point-of-care diagnostic market, focusing initially on ...
Breaking Biology Technology:
Cached News: